• We The Patients Fly-In
  • Events Calendar
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
  • Donate

Tag: drug rebate

Statement on HHS Proposal to Target Rebates and Pass the Savings on to Patients

Aug 6, 2019 | Medicare Part D, News

Patients Rising Now welcomes the proposed changes by the Trump Administration aiming to lower costs for patients by targeting backdoor rebates and encouraging direct discounts to those who receive their health care through Medicare/Medicaid.    The current drug...
Read more
This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

This one reform could immediately lower patient drug costs. Insurance companies and pharmacy benefit managers just blocked it.

Jul 23, 2019 | Drug Costs, News, Pharmacy Benefit Managers

As the year began, patients seeking relief from high out-of-pocket health care costs had reason to be optimistic. A proposed rule introduced by the Department of Health and Human Services would have stopped pharmacy benefit managers and insurance companies from...
Read more

Categories

  • Access
  • Actions
  • California
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA H.R.3 Healthcare Inequities Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden Lupus medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Can Mark Cuban Deliver Cheaper RX? – Season 3 | Episode 20
  • What is the Future of Co-pay Accumulator and Maximizer Programs? 
  • Have Health Plans Abandoned Rare Disease Patients?: Season 3 | Episode 19
  • Patients Rising Now Pens Letter Regarding S.2910: The Expanding Access to Low-Cost Generics Act of 2021
  • OIG Report Tags Biosimilars for Medicare and Beneficiary Savings

Sign up for updates

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2022 Patients Rising Now